Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Shephali Singh"'
Publikováno v:
Journal of Anaesthesiology Clinical Pharmacology, Vol 39, Iss 4, Pp 661-662 (2023)
Externí odkaz:
https://doaj.org/article/df81981d32814334a5c98b870da4d32a
Publikováno v:
Journal of Clinical Anesthesia. 88:111119
Autor:
Shephali Singh, Divesh Bhatia
Publikováno v:
Chemical Engineering Research and Design. 147:458-469
The phenomenon of simultaneous diffusion, reaction, and external mass transfer in a spherical catalyst particle is studied for a reaction exhibiting negative order with respect to the reactant species. With external mass transfer considered, it is sh
Autor:
Shephali Singh, Divesh Bhatia
Publikováno v:
Chemical Engineering Journal. 354:525-540
A global kinetic model for NH3 oxidation is developed and incorporated into an existing LNT-SCR kinetic model to study its effect on the performance of dual-layer and mixed LNT-SCR configurations. The model predicts a decrease in the NOx conversion a
Publikováno v:
International Journal of Scientific and Research Publications (IJSRP). 9:p96113
Autor:
Shephali Singh, Divesh Bhatia
Publikováno v:
Chemical Engineering Journal. 377:120311
Kinetic models for CO-NO2 and C3H6-NO2 reactions are developed to analyze the effect of the reductant species on NH3-SCR reactions over a Cu-CHA monolithic catalyst. A nitrate-based mechanism is used to predict the reduction of NO2 by CO, for which a
Autor:
R. C. Gurjar, Shephali Singh
Publikováno v:
2017 International Conference on Recent Innovations in Signal processing and Embedded Systems (RISE).
Thispaper presentedthe LC VCO design with varactor bank based on the selection of passive elements. A negative CMOS cross coupled pair is added to reduce losses and improves quality factor. This configuration is selected due to ease of oscillation an
Publikováno v:
International Journal of Basic & Clinical Pharmacology. 6:2434
Background: Diabetes Mellitus (DM) is a metabolic disorder characterized by hyperglycemia. In majority of patients oral hypoglycemic drugs remain the primary agents in management of DM. Currently there are variety of new drugs are approved in managem